ASX - Delayed Quote AUD

Imricor Medical Systems, Inc. (IMR.AX)

Compare
1.3000
-0.1000
(-7.14%)
At close: 4:10:38 PM GMT+11
Loading Chart for IMR.AX
  • Previous Close 1.4000
  • Open 1.3900
  • Bid 1.2550 x --
  • Ask 1.3000 x --
  • Day's Range 1.1950 - 1.3900
  • 52 Week Range 0.4100 - 1.7100
  • Volume 1,259,650
  • Avg. Volume 276,990
  • Market Cap (intraday) 448.454M
  • Beta (5Y Monthly) -0.20
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2100
  • Earnings Date Feb 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.40

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

www.imricor.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IMR.AX

View More

Performance Overview: IMR.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

IMR.AX
4.41%
MSCI WORLD (^990100-USD-STRD)
8.70%

1-Year Return

IMR.AX
120.34%
MSCI WORLD (^990100-USD-STRD)
0.03%

3-Year Return

IMR.AX
136.36%
MSCI WORLD (^990100-USD-STRD)
9.86%

5-Year Return

IMR.AX
53.85%
MSCI WORLD (^990100-USD-STRD)
90.52%

Compare To: IMR.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IMR.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    416.42M

  • Enterprise Value

    425.21M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    190.10

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    277.59

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -68.06%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    959.42k

  • Net Income Avi to Common (ttm)

    -29.69M

  • Diluted EPS (ttm)

    -0.2100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.71M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -10.41M

Research Analysis: IMR.AX

View More

Company Insights: IMR.AX

Research Reports: IMR.AX

View More

People Also Watch